RecruitingNot ApplicableNCT06485700

Peers and Technology for Adherence, Access, Accountability, and Analytics (PT4A)


Sponsor

NYU Langone Health

Enrollment

1,140 participants

Start Date

Nov 18, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Peer-based medication delivery decreases the cost of transportation and the opportunity cost of travel while HIT can support peer activities by facilitating targeted adherence counseling, teleconsultation, synchronization of clinical care, and pharmacy activities. The investigators have implemented a pilot program of door-to-door peer-based medication delivery and HIT in western Kenya, and preliminary data indicate improved adherence and blood pressure. However, the effectiveness of this implementation strategy is not fully established. Therefore, the objective of the study is to use the PRECEDE-PROCEED framework to conduct transdisciplinary implementation research to test the hypothesis that integrating peer delivery of medications with HIT (PT4A) improves medication adherence and reduces blood pressure among patients with uncontrolled hypertension in western Kenya.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • • Adult participants enrolled in AMPATH's CDM Program with uncontrolled hypertension (SBP ≥ 140 or diastolic BP (DBP) ≥ 90)

Exclusion Criteria3

  • hypertensive emergency requiring immediate medical attention,
  • terminal illness, and
  • inability to provide informed consent.

Interventions

OTHERPeer Delivery of Medications

Door-to-door peer delivery of medications within patients' communities will be implemented.

OTHERHealth Information Technology (HIT) Platform

The HIT platform provides: 1) tailored counseling strategies through decision support; 2) teleconsultation support for clinician-peer-patient interactions; 3) medication refill tracking to enhance accountability of the peer delivery process; and 4) analytics to improve medication supply chain by generating patient-level drug consumption data.


Locations(3)

Study Site

Webuye, Bungoma County, Kenya

Study Site

Kitale, Trans Nzoia County, Kenya

Study Site

Eldoret, Uasin Gishu County, Kenya

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06485700


Related Trials